Conference Coverage

Incident Chronic Kidney Disease Following Kidney Cancer Surgery

Lamberts R, Thomas I, Chung B, Sonn G, Fan A, Srinivas S, Wagner T, Chertow G, Brooks J, Leppert JT

Abstract 48: 2015 AVAHO Meeting


 

References

Background: We sought to characterize the risk of clinically significant chronic kidney disease (CKD) following radical nephrectomy (RN) or partial nephrectomy (PN). We examined kidney function outcomes using data from the VHA. The VHA is the largest integrated national health care system in the U.S. and uses a standardized electronic health record, including measures of vital signs, laboratory values, and cancer-specific data.

Methods: We identified patients treated with RN or PN in the VHA from 2001 to 2013. We extracted all available measures of preoperative kidney function (N = 120,746), postoperative kidney function (N = 584,043), and tumor-specific data. For patients with preoperative epidermal growth factor receptor (eGFR) > 30, we fit proportional hazards models to test the association with RN and the outcome of stage 4 CKD (eGFR < 30 or dialysis). We performed a parallel analysis of patients with normal or near-normal preoperative kidney function (eGFR ≥ 60) and the incidence of stage 3b CKD (eGFR < 45). We fit adjusted competing risks models to determine the risk of CKD or death.

Results: We identified a cohort of 14,129 patients with preoperative eGFR > 30 who underwent kidney cancer surgery with either RN (n = 9,759) or PN (n = 4,370). Patients treated with PN had a > 50% reduced risk (hazard ratio [HR] 0.49, 95% confidence interval [CI] 0.42-0.58) of stage 4 CKD (eGFR < 30) in our multivariable model after controlling for age, sex, race, comorbidities, year of surgery, and preoperative kidney function. This association remained (HR 0.39, 95% CI 0.32-0.48) after controlling for T stage in patients with tumor-specific data (N = 8,598). Patients with normal or near-normal preoperative kidney function (N = 8,089) treated with PN had a > 80% reduced risk (HR 0.17, 95% CI 0.14-0.21) of developing stage 3b CKD (eGFR < 45) compared with that of RN. All associations remained significant in our competing risk multivariable model.

Conclusions: Partial nephrectomy is associated with marked reduction in the incidence of clinically significant CKD com-pared with that of RN.

Recommended Reading

A Veterans Health Administration Disease Management Program: The Hudson Valley Model
AVAHO
Bombesin Research: The Prostate Cancer Connection
AVAHO
Audiologic Rehabilitative Service Utilization Among Veterans Exposed to Cisplatin: A Retrospective Review
AVAHO
Veterans With Castration-Resistant Prostate Cancer: Characteristics and Treatment
AVAHO
Best Practices: Utilization of Oncology Pharmacists in the VA
AVAHO
Prevalence of Prostate-Specific Antigen Testing Informed Consent Among Veteran Males Aged 55 to 69 Years
AVAHO
Making Distress Screening Useful for Nursing and Social Work
AVAHO
PSA Response Rates Far Exceeded Expectations in Treating Asymptomatic, Androgen-Resistant Prostate Cancer With Abiraterone
AVAHO
The Efficacy of Abiraterone Pre-and Postdocetaxel and Sequential Use of Enzalutamide After Abiraterone in Veteran Patients With Metastatic Castration-Resistant Prostate Carcinoma
AVAHO
Improving the Accuracy of Ordering and Reporting for Send-Out Laboratory Studies
AVAHO